This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

    More

    Page   1/4   
  • Health care current: April 22, 2014
    This weekly series explores breaking news and developments in the U.S. health care industry, examines key issues facing life sciences and health care companies and provides updates and insights on policy, regulatory and legislative changes.
  • The quest for value in health care: A place for consumers
    Three key disrupters are driving an increasingly consumer-centric health care system. How are consumers responding? What are the implications for the industry? And what steps can health care providers, health plans and life sciences companies consider to help win in this new marketplace?
  • Health care reform: Redefining biopharma innovation
    Health care reform encompasses legislation that has been signed in the recent past related to the access and delivery of healthcare, notably the Affordable Care Act (ACA) passed in 2010, as well as broader, nonreversible trends in the market. Reform culminates into a heightened focus on reducing cost while increasing the quality of care, which will likely force a new definition of innovation to emerge for biopharma.
  • Mapping out health care reform: Activity in the states
    How many individuals have selected a plan on the health insurance exchanges? What decisions are states making around Medicaid expansion? How many medical insurance carriers are competing in states' individual markets in 2014? Check out these maps to find out.
  • 2014 U.S. Outlooks for Life Sciences, Providers & Health Plans: Challenges, trends and strategies that may shape your business
    Deloitte LLP leaders Bill Copeland, Mitch Morris and Terry Hisey discuss the biggest challenges, opportunities and trends for the health care industry in 2014.
  • Invigorating biopharma: How the three rules can drive superior performance
    Though changing industry dynamics may call for a focus on cost containment in the short term, biopharma companies can emerge with new strategies that are again oriented toward non-price value and growth.
  • Health care costs, benefits and reform: What’s the next move for employers?
    Deloitte’s 2013 survey of U.S. employers reveals concern and uncertainty about health care system performance, Affordable Care Act (ACA) preparedness, cost-reduction strategies and the quest to find value.
  • Networked medical device cybersecurity and patient safety: Perspectives of health care information cybersecurity executives
    Health care information cybersecurity executives discuss their challenges, activities, and thoughts about networked medical device governance, risk management and cybersecurity.
  • Will they come? Consumers and health insurance exchanges: Awareness, preferences and concerns
    Deloitte’s 2013 consumer survey reveals a lack of awareness around health insurance exchange (HIX) details and worries about cost. Engaging and informing consumers can help to convert interest into enrollment.
  • Physician-hospital employment: This time it’s different
    Hospitals have been employing physicians at increasing rates, driven mainly by broader health care system transformation. Earlier waves of physician-hospital consolidation ended, for many, with divesture. This time hospitals cannot afford to fail.
  • Page   1/4